HERON THERAPEUTICS, INC. /DE/ Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2026-06-30: Preferred Stock, Value, Issued $1.05M.
- 2026-03-31: Preferred Stock, Value, Issued $1.05M.
- 2025-12-31: Preferred Stock, Value, Issued $1.05M; Preferred Stock, Par or Stated Value Per Share $0.01; Preferred Stock, Shares Authorized 2.50M shares; Preferred Stock, Shares Issued 70.01K shares.
- 2025-09-30: Preferred Stock, Value, Issued $7.86M.
| Period end | Preferred Stock, Value, Issued | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, Shares Authorized | Preferred Stock, Shares Issued | Preferred Stock, Shares Outstanding |
|---|---|---|---|---|---|
| 2026-06-30 | $1.05M 10-Q · filed 2026-08-10 | ||||
| 2026-03-31 | $1.05M 10-Q · filed 2026-05-11 | ||||
| 2025-12-31 | $1.05M 10-Q · filed 2026-08-10 | $0.01 10-K · filed 2026-02-26 | 2.50M shares 10-K · filed 2026-02-26 | 70.01K shares 10-K · filed 2026-02-26 | 70.01K shares 10-K · filed 2026-02-26 |
| 2025-09-30 | $7.86M 10-Q · filed 2025-11-04 | ||||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | $0.01 10-K · filed 2026-02-26 | 2.50M shares 10-K · filed 2026-02-26 | 0.00 shares 10-K · filed 2026-02-26 | 0.00 shares 10-K · filed 2026-02-26 |
| 2023-12-31 | $0.01 10-K · filed 2024-03-12 | 2.50M shares 10-K · filed 2024-03-12 | 0.00 shares 10-K · filed 2024-03-12 | 0.00 shares 10-K · filed 2024-03-12 | |
| 2022-12-31 | $0.01 10-K · filed 2024-03-12 | 2.50M shares 10-K · filed 2024-03-12 | 0.00 shares 10-K · filed 2024-03-12 | 0.00 shares 10-K · filed 2024-03-12 | |
| 2021-12-31 | $0.01 10-K · filed 2023-03-29 | 2.50M shares 10-K · filed 2023-03-29 | 0.00 shares 10-K · filed 2023-03-29 | 0.00 shares 10-K · filed 2023-03-29 | |
| 2020-12-31 | $0.01 10-K · filed 2022-02-28 | 2.50M shares 10-K · filed 2022-02-28 | 0.00 shares 10-K · filed 2022-02-28 | 0.00 shares 10-K · filed 2022-02-28 | |
| 2019-12-31 | $0.01 10-K · filed 2021-02-24 | 2.50M shares 10-K · filed 2021-02-24 | 0.00 shares 10-K · filed 2021-02-24 | 0.00 shares 10-K · filed 2021-02-24 | |
| 2018-12-31 | $0.01 10-K · filed 2020-03-02 | 2.50M shares 10-K · filed 2020-03-02 | 0.00 shares 10-K · filed 2020-03-02 | 0.00 shares 10-K · filed 2020-03-02 | |
| 2017-12-31 | $0.01 10-K · filed 2019-02-22 | 2.50M shares 10-K · filed 2019-02-22 | 0.00 shares 10-K · filed 2019-02-22 | 0.00 shares 10-K · filed 2019-02-22 | |
| 2016-12-31 | $0.00 10-K · filed 2017-02-23 | $0.01 10-K · filed 2018-02-27 | 2.50K shares 10-K · filed 2018-02-27 | 0.00 shares 10-K · filed 2018-02-27 | 0.00 shares 10-K · filed 2018-02-27 |
| 2015-12-31 | $0.00 10-K · filed 2017-02-23 | $0.01 10-K · filed 2017-02-23 | 2.50M shares 10-K · filed 2017-02-23 | 0.00 shares 10-K · filed 2017-02-23 | 0.00 shares 10-K · filed 2017-02-23 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-19 | $0.01 10-K · filed 2016-02-19 | 2.50M shares 10-K · filed 2016-02-19 | 0.00 shares 10-K · filed 2016-02-19 | 0.00 shares 10-K · filed 2016-02-19 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-13 | $0.01 10-K · filed 2015-03-13 | 2.50M shares 10-K · filed 2015-03-13 | 0.00 shares 10-K · filed 2015-03-13 | 0.00 shares 10-K · filed 2015-03-13 |
| 2012-12-31 | $0.00 10-K · filed 2014-03-07 | 2.50M shares 10-K · filed 2014-03-07 | 0.00 shares 10-K · filed 2014-03-07 | 0.00 shares 10-K · filed 2014-03-07 | |
| 2011-12-31 | 2.50M shares 10-K · filed 2013-03-01 | ||||
| 2010-12-31 | 2.50M shares 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |